Literature DB >> 19322628

Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases.

Liming Bao1,2,3, Sherilyn A Gross1,4, John Ryder5, Xiaoqin Wang1,6, Meirong Ji6, Yan Chen1, Yongchen Yang1, Saijuan Zhu1, Richard D Irons7,8,9,10.   

Abstract

Acute lymphoblastic leukemia (ALL) accounts for 20-30% of adult leukemia in the West. However, detailed studies of B-cell-specific ALL in adult Asian populations are lacking. We diagnosed and characterized 137 consecutive cases of precursor B lymphoblastic leukemia (precursor B-cell ALL) presented to our laboratory in Shanghai using the WHO 2001 classification system. Patient clinical, phenotypic and cytogenetic characteristics were correlated with outcome. In contrast to Western studies, females (71) outnumbered males (66) partly due to an increased prevalence of the CD10- pro B-cell phenotype. Females with a CD10- pro B-cell phenotype exhibited significantly better overall survival than males. The most common cytogenetic abnormality was the Philadelphia chromosome (PH/BCR/ABL) which was found in approximately 37% of the cases. Cases of precursor B cell ALL lacking the PH/BCR/ABL genotype exhibited a pronounced age-dependent, gender prevalence with a modal age in the sixth decade for females compared to the second decade for males. These findings suggest significant geographic heterogeneity in precursor B-cell ALL which may be of both etiological and therapeutic significance.

Entities:  

Mesh:

Year:  2009        PMID: 19322628     DOI: 10.1007/s12185-009-0283-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  28 in total

1.  Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL) - frequency and correlation with immunophenotype.

Authors:  Milena Velizarova; Dora Popova; Evgenii Hadjiev; Kamelia Aleksandrova; Ivanka Dimova; Boriana Zaharieva; Stavri Toshkov; Mimoza Staneva; Djansaran Hodjajik; Marin Penev; Draga Toncheva
Journal:  Turk J Haematol       Date:  2006-09-05       Impact factor: 1.831

2.  The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Seok Lee; Yoo-Jin Kim; Chang-Ki Min; Hee-Je Kim; Ki-Sung Eom; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

Review 3.  The biology and treatment of acute lymphoblastic leukemia in adults.

Authors:  E A Copelan; E A McGuire
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

4.  Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome.

Authors:  Roch Houot; Emmanuelle Tavernier; Quoc-Hung Le; Véronique Lhéritier; Anne Thiebaut; Xavier Thomas
Journal:  Hematology       Date:  2004 Oct-Dec       Impact factor: 2.269

5.  Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Authors:  S Faderl; H M Kantarjian; D A Thomas; J Cortes; F Giles; S Pierce; M Albitar; Z Estrov
Journal:  Leuk Lymphoma       Date:  2000-01

6.  [Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia].

Authors:  Jing-Ying Qiu; Wei Zhu; Yan Zhang; Shan-Shan Chen; Bin Jiang; Hui-Ling Shi; Yan Shi; Qi He; Hui Dang; De-Bing Wang; Dao-Pei Lu
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2005-06

7.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Authors:  R A Larson; R K Dodge; C P Burns; E J Lee; R M Stone; P Schulman; D Duggan; F R Davey; R E Sobol; S R Frankel
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

8.  Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.

Authors:  Bor-Sheng Ko; Jih-Lu Tang; Fen-Yu Lee; Ming-Chi Liu; Woei Tsai; Yao-Chang Chen; Chiu-Hwa Wang; Ming-Chin Sheng; Dong-Tsam Lin; Kai-Hsin Lin; Hwei-Fang Tien
Journal:  Am J Hematol       Date:  2002-12       Impact factor: 10.047

Review 9.  Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review.

Authors:  L M Secker-Walker; J M Craig
Journal:  Leukemia       Date:  1993-02       Impact factor: 11.528

10.  A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China.

Authors:  Sherilyn A Gross; Xiongzeng Zhu; Liming Bao; John Ryder; Anh Le; Yan Chen; Xiao Qin Wang; Richard D Irons
Journal:  Int J Hematol       Date:  2008-07-23       Impact factor: 2.490

View more
  3 in total

1.  Acute lymphoblastic leukemia in elderly patients: a single institution's experience.

Authors:  Dong-Yeop Shin; Inho Kim; Ki-Hwan Kim; Younak Choi; Seung Hoon Beom; Yaewon Yang; Yoojoo Lim; Eunyoung Lee; June Koo Lee; Ji Yeon Kim; Hyun Kyung Kim; Sung-Soo Yoon; Dong Soon Lee; Seonyang Park; Byoung-Kook Kim
Journal:  Korean J Intern Med       Date:  2011-09-13       Impact factor: 2.884

2.  An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia.

Authors:  Jun Ma; Ting Liu; Jie Jin; Jianda Hu; Qifa Liu; Jianxiang Wang; Zhixiang Shen; Xin Du; Bin Jiang; Xianhua Meng
Journal:  Int J Hematol Oncol       Date:  2018-07-25

3.  Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients

Authors:  Dikshat Gopal Gupta; Neelam Varma; Shano Naseem; Man Updesh Singh Sachdeva; Parveen Bose; Jogeshwar Binota; Ashish Kumar; Minakshi Gupta; Palak Rana; Preeti Sonam; Pankaj Malhotra; Amita Trehan; Alka Khadwal; Subhash Varma
Journal:  Turk J Haematol       Date:  2021-10-07       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.